Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pristiq in Generalized Social Anxiety Disorder
NCT01316302Phase 4Completed
- Sponsor
- Medical Research Network
- Start
- Apr 2011
- Primary completion
- Nov 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Social Anxiety Disorder (SAD) comparing Pristiq with Placebo (2 arms). Primary endpoint: Liebowitz Social Anxiety Scale Total Score at 12 weeks. Started Apr 2011; status: completed.
02
Drugs
desvenlafaxine
03
Conditions
Social Anxiety Disorder (SAD)
Beyond the preview
Go deeper on NCT01316302.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01316302.